⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JBIO News
Jade Biosciences, Inc. Common Stock
Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
JBIO
Form 8-K
sec.gov
JBIO
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
globenewswire.com
JBIO
ASTL
Form 8-K
sec.gov
JBIO
Form 8-K
sec.gov
JBIO
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
JBIO
Jade Biosciences to Participate in Upcoming Conferences
globenewswire.com
JBIO
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
JBIO
Jade Biosciences Announces $45 Million Private Placement
globenewswire.com
JBIO
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
JBIO